Video

Dr. Parikh on the Importance of Multidisciplinary Care in HCC

Neehar Parikh, MD, discusses the importance of multidisciplinary care in the treatment of patients with hepatocellular carcinoma.

Neehar Parikh, MD, medical director, Multidisciplinary Liver Tumor Clinic, Living Donor Liver Transplantation Program, assistant professor, Michigan Medicine, University of Michigan, discusses the importance of multidisciplinary care in the treatment of patients with hepatocellular carcinoma (HCC).

Patients with HCC are commonly treated by a multidisciplinary team in the university setting, says Parikh. These groups consist of hepatologists, interventional radiologists, oncologists, diagnostic radiologists, and palliative care specialists, says Parikh.

These teams work as a single unit to optimize treatment for patients and address any complications that arise, says Parikh.

Importantly, analyses suggest that there is a survival advantage when patients who receive curative intent therapy are treated by a multidisciplinary team compared with those treated by a single physician, concludes Parikh.

Related Videos
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Ana Christina Garrido-Castro, MD
Jennifer R. Eads, MD, physician lead, GI Cancer Research, director, National Clinical Trials Network, Abramson Cancer Center, University of Pennsylvania, associate professor, clinical medicine (hematology-oncology), Penn Medicine, Perelman Center for Advanced Medicine
Jean-Marc Classe, MD, PhD, Nantes Université
Bradley McGregor, MD
Kevin Kalinsky, MD, MS
Olivia Aranha, MD, PhD
Michael Iglesia, MD, PhD
Petros Grivas, MD, PhD; and Chandler Park, MD, MSc, FACP